About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Lygos Successfully Completes Commercial-Scale Fermentation Campaign to Meet Growing Demand for Bio-based Cannabinoids

Proprietary fermentation-based pathway performs at scale and delivers highly pure, consistent, and natural CBG, CBC, CBD, CBDA, and CBDV

Lygos, Inc., a vertically integrated provider of safe and sustainable specialty ingredients, today announced that it has successfully completed commercial-scale, fermentation-based production campaigns for its Lygos CBx cannabinoid products, including CBG (cannabigerol), CBC (cannabichromene), CBD (cannabidiol), and CBDA (cannabidiolic acid). These campaigns validate the company’s ability to produce a variety of high-quality cannabinoids and cannabinoid-based products for a growing number of recreational, health & wellness, and pharmaceutical applications, all in an environmentally safe, sustainable, and cost-effective manner.

The company also recently demonstrated the ability to produce CBDV (cannabidivarin) and plans to expand its offerings to include other products that fall within the “varin” cannabinoid class. With these campaigns, Lygos CBx has demonstrated an ability to control many forms of cannabinoid structure with respect to the acidic vs neutral form, terpenoid variants, and alkyl chain length.

“Lygos’ leading sustainable production technology provides a high-performance and on-demand alternative to agricultural-based cannabinoid production,” said Eric Steen, PhD, CEO of Lygos. “With these recent production and scalability milestones, we continue to showcase our innovation beyond the plant and demonstrate our ability to provide high-quality, traceable, and natural cannabinoids with bioidentical equivalent performance. Together with our partners, we are now uniquely positioned to capitalize on the many high-growth opportunities around the world for CBD and these varin-derivatives.”

Lygos CBx’ novel fermentation-based pathway enables the production of highly pure, bio-based cannabinoids. According to a study in Frontiers in Genetics, traditional plant-based CBD production requires heavy use of fertilizers, pesticides, energy, and water, and often results in THC levels that exceed the regulatory limits for many commercial applications. Purely synthetic cannabinoid production can also contain halogenated impurities, which can be toxic to humans and other animals. The Lygos technology produces precise, specific, and isolated cannabinoids and avoids issues of separation, purification, and environmental concerns compared to plant-based production. The production platform features important quality control measures that eliminate THC and other harmful contaminants. The modular platform has been used to produce a variety of natural molecules in both acidic and decarboxylated forms and create cannabinoid-like derivatives for pharmaceutical applications that target the human endocannabinoid system.

Lygos currently offers a full menu of common, rare or novel cannabinoids, along with leading bulk supply, formulation, custom synthesis, and efficacy services to help meet the particular needs of its current and future customers in consumer products and pharmaceuticals industries. Lygos is actively collaborating and co-developing cannabinoid-based products with industry-leading companies. The company plans to launch additional consumer products in the coming year.

About Lygos CBx

Lygos CBx is a Lygos company focused on low-cost, industrial-scale production of a wide range of high-quality, pure, and sustainable cannabinoid compounds that are not easily accessible through traditional agricultural means. The cannabinoids are designed to enhance numerous consumer products, as well as health & wellness and pharmaceutical applications. For more information, visit cbx.lygos.com.

About Lygos

Lygos has created a full-stack biological engineering platform focused on organic acid specialty ingredients, health & wellness ingredients, including cannabinoids and bio-monomers. Lygos’ sustainable, bio-based chemicals replace expensive, environmentally degrading alternatives from traditional industrial suppliers, enabling customers to create better, safer products with value-added performance. For more information, visit www.lygos.com and follow us @LygosBiotech.

*Lygos CBx CBD product has been measured as ‘non-detect’ THC by an independent cannabis testing laboratory using a sensitive technique with a detection limit of 2 ppm (2mg/kg).

Lygos, Lygos CBx, and the Lygos and Lygos CBx logos are trademarks of Lygos, Inc. Any other brands may be trademarks of their respective holders.

@LygosBiotech successfully completed a commercial-scale, fermentation-based campaign for its #cannabinoid products, including #CBG, #CBC , #CBD, and #CBDA

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.29
+4.84 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.16
+1.35 (0.74%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.